Grant: Canadian Lung Association Research Studentship
University of Toronto
$9,000.00
Respiratory Oscillometry for Early Diagnosis of Chronic Lung Allograft Dysfunction
FY 2022-23
Summary
This is the first study using oscillometry to predict development of CLAD. Our study results may help to diagnose CLAD earlier, enable clinical studies for evaluate potential therapies, and improve patient survival.
Lung transplantation (LTx) is an established treatment option for patients with end-stage lung diseases. While survival following LTx has steadily improved, chronic rejection, known as chronic lung allograft dysfunction (CLAD) remains the main barrier. CLAD develops in over half of the patients by 5 years after LTx. The only treatment is another transplant. The
diagnosis of CLAD is an irreversible decline (=20% from baseline) in the forced expiratory volume in 1 second (FEV1) for at least 3 months. This means CLAD cannot be confirmed until 3 months after onset, hampering clinical trials of potential new therapies. CLAD has two different clinical presentations. The disease process is different, as one has significantly worse
survival than the other and may require different tailored management. Oscillometry, a novel lung function test, is highly sensitive to changes in the lung tissue. Work in our group showed it to be more sensitive than spirometry in detecting acute rejection, and my first-authored paper found that oscillometry can differentiate between the different types of CLAD at time of the first drop in FEV1 and from patients without CLAD.
We hypothesis that oscillometry can detect early signs of lung dysfunction to identify patients at risk of rejection. The aim of this project is to conduct predictive analysis of oscillometry in the post-transplant follow-up of patients to identify CLAD.
Over 550 patients from the Toronto Lung Transplant Program with at least 2 years of follow-up are already enrolled in an ongoing prospective observational study of oscillometry post-lung transplant. The Toronto Lung Transplant Research Database maintains an up-to-date comprehensive lifelong clinical data off all patients. We will conduct a comprehensive
analysis the data. We will use one-way analysis-of-variance and paired tests to characterize the oscillometry patterns between patients with and without chronic rejection and identify key differences. To generate a predictive model, we will employ logistic regression model toforecast relationships between oscillometry parameters CLAD and CLAD phenotypes.
Findings from our study is expected to identify earlier patients at risk CLAD, paving the way for future studies of new therapeutic s or interventions before CLAD is established.CLAD is the biggest obstacle to long term survival post-transplant. Due to the scarcity of lungs, and the intensive resource expanded for each patient, it is imperative to develop therapies that can improve life expectancy and reduce morbidity post-transplant.
Department
Program
Canadian Lung Association Research Studentship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
476981
Name
Fu Anne
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Lung Association (Ottawa)
Prcname2
Special Cases
Projecttitle
Respiratory Oscillometry for Early Diagnosis of Chronic Lung Allograft Dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$9,000
Cihrequipment2
$0
Programname2
Canadian Lung Association Research Studentship
Keyworddelim
Chronic Lung Allograft Dysfunction; Lung Mechanics; Lung Transplantation; Oscillometry; Pulmonary Function Testing
Abstract
This is the first study using oscillometry to predict development of CLAD. Our study results may help to diagnose CLAD earlier, enable clinical studies for evaluate potential therapies, and improve patient survival.
Lung transplantation (LTx) is an established treatment option for patients with end-stage lung diseases. While survival following LTx has steadily improved, chronic rejection, known as chronic lung allograft dysfunction (CLAD) remains the main barrier. CLAD develops in over half of the patients by 5 years after LTx. The only treatment is another transplant. The
diagnosis of CLAD is an irreversible decline (=20% from baseline) in the forced expiratory volume in 1 second (FEV1) for at least 3 months. This means CLAD cannot be confirmed until 3 months after onset, hampering clinical trials of potential new therapies. CLAD has two different clinical presentations. The disease process is different, as one has significantly worse
survival than the other and may require different tailored management. Oscillometry, a novel lung function test, is highly sensitive to changes in the lung tissue. Work in our group showed it to be more sensitive than spirometry in detecting acute rejection, and my first-authored paper found that oscillometry can differentiate between the different types of CLAD at time of the first drop in FEV1 and from patients without CLAD.
We hypothesis that oscillometry can detect early signs of lung dysfunction to identify patients at risk of rejection. The aim of this project is to conduct predictive analysis of oscillometry in the post-transplant follow-up of patients to identify CLAD.
Over 550 patients from the Toronto Lung Transplant Program with at least 2 years of follow-up are already enrolled in an ongoing prospective observational study of oscillometry post-lung transplant. The Toronto Lung Transplant Research Database maintains an up-to-date comprehensive lifelong clinical data off all patients. We will conduct a comprehensive
analysis the data. We will use one-way analysis-of-variance and paired tests to characterize the oscillometry patterns between patients with and without chronic rejection and identify key differences. To generate a predictive model, we will employ logistic regression model toforecast relationships between oscillometry parameters CLAD and CLAD phenotypes.
Findings from our study is expected to identify earlier patients at risk CLAD, paving the way for future studies of new therapeutic s or interventions before CLAD is established.CLAD is the biggest obstacle to long term survival post-transplant. Due to the scarcity of lungs, and the intensive resource expanded for each patient, it is imperative to develop therapies that can improve life expectancy and reduce morbidity post-transplant.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fu, Anne
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $9,000~ $0~